Patents by Inventor Farid Ghadessy

Farid Ghadessy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7622280
    Abstract: An emulsion is useful in allowing a wide variety of gene products to be expressed via eukaryotic in vitro expression. The emulsion comprises a silicone based surfactant, a hydrophobic phase and a hydrophilic phase; wherein the hydrophilic phase comprises a plurality of compartments containing a functional in vitro eukaryotic expression system.
    Type: Grant
    Filed: June 11, 2004
    Date of Patent: November 24, 2009
    Assignee: 454 Life Sciences Corporation
    Inventors: Phillip Holliger, Farid Ghadessy
  • Publication number: 20090246853
    Abstract: We describe a method of selecting an enzyme having replicase activity, the method comprising the steps of: (a) providing a pool of nucleic acids comprising members each encoding a replicase or a variant of the replicase; (b) subdividing the pool of nucleic acids into compartments, such that each compartment comprises a nucleic acid member of the pool together with the replicase or variant encoded by the nucleic acid member; (c) allowing nucleic acid replication to occur; and (d) detecting amplification of the nucleic acid member by the replicase. Methods for selecting agents capable of modulating replicase activity, and for selecting interacting polypeptides are also disclosed.
    Type: Application
    Filed: February 25, 2009
    Publication date: October 1, 2009
    Applicant: Medical Research Council
    Inventors: Phillipp Holliger, Farid Ghadessy, Jennifer Lee Ong
  • Publication number: 20090053689
    Abstract: The present invention relates to a device and an apparatus device for processing a biological and/or chemical sample. The device comprises at least one sample processing chamber having an inlet at a first end and a penetrable sealing layer at a second end that forms at least a part of an inner wall of the sample processing chamber. The sealing layer is adapted to seal off the sample processing chamber from the environment until said sealing layer is penetrated to form an outlet. The device and apparatus also includes an absorption layer, wherein upon penetration of said sealing layer, said absorption layer is in fluid contact with said sealing layer and is capable of absorbing fluid released from said sample processing chamber, via the outlet. The present invention also relates to a fluid separation device. The fluid separation device comprises a penetrable sealing layer adapted to form a wall of a sample processing chamber of the device of the invention.
    Type: Application
    Filed: July 19, 2005
    Publication date: February 26, 2009
    Applicant: ATTOGENIX BIOSYSTEMS PTE. LTD
    Inventors: Dominador Fortaleza Oviso, JR., Dor Ngi Ting, Farid Ghadessy, Hui Wang, Wen Jian Lau
  • Patent number: 7429467
    Abstract: An emulsion is useful in allowing a wide variety of gene products to be expressed via eukaryotic in vitro expression. The emulsion comprises a silicone based surfactant, a hydrophobic phase and a hydrophilic phase; wherein the hydrophilic phase comprises a plurality of compartments containing a functional in vitro eukaryotic expression system.
    Type: Grant
    Filed: May 13, 2004
    Date of Patent: September 30, 2008
    Assignee: Medical Research Council
    Inventors: Phillip Holliger, Farid Ghadessy
  • Publication number: 20080187968
    Abstract: An emulsion is useful in allowing a wide variety of gene products to be expressed via eukaryotic in vitro expression. The emulsion comprises a silicone based surfactant, a hydrophobic phase and a hydrophilic phase; wherein the hydrophilic phase comprises a plurality of compartments containing a functional in vitro eukaryotic expression system.
    Type: Application
    Filed: March 28, 2008
    Publication date: August 7, 2008
    Inventors: Phillip Holliger, Farid Ghadessy
  • Publication number: 20070020653
    Abstract: The present invention relates to DNA polymerases. In particular the invention relates to a method for the generation of DNA polymerases exhibiting a relaxed substrate specificity. Uses of mutant polymerases produced using the methods of the invention are also described.
    Type: Application
    Filed: May 3, 2006
    Publication date: January 25, 2007
    Inventors: Philipp Holliger, Farid Ghadessy, Marc D'Abbadie
  • Publication number: 20050064460
    Abstract: An emulsion is useful in allowing a wide variety of gene products to be expressed via eukaryotic in vitro expression. The emulsion comprises a silicone based surfactant, a hydrophobic phase and a hydrophilic phase; wherein the hydrophilic phase comprises a plurality of compartments containing a functional in vitro eukaryotic expression system.
    Type: Application
    Filed: June 11, 2004
    Publication date: March 24, 2005
    Inventors: Phillip Holliger, Farid Ghadessy
  • Publication number: 20040253731
    Abstract: An emulsion is useful in allowing a wide variety of gene products to be expressed via eukaryotic in vitro expression. The emulsion comprises a silicone based surfactant, a hydrophobic phase and a hydrophilic phase; wherein the hydrophilic phase comprises a plurality of compartments containing a functional in vitro eukaryotic expression system.
    Type: Application
    Filed: May 13, 2004
    Publication date: December 16, 2004
    Applicant: Medical Research Council
    Inventors: Phillip Holliger, Farid Ghadessy
  • Publication number: 20040005594
    Abstract: We describe a method of selecting an enzyme having replicase activity, the method comprising the steps of: (a) providing a pool of nucleic acids comprising members each encoding a replicase or a variant of the replicase; (b) subdividing the pool of nucleic acids into compartments, such that each compartment comprises a nucleic acid member of the pool together with the replicase or variant encoded by the nucleic acid member; (c) allowing nucleic acid replication to occur; and (d) detecting amplification of the nucleic acid member by the replicase. Methods for selecting agents capable of modulating replicase activity, and for selecting interacting polypeptides are also disclosed.
    Type: Application
    Filed: March 13, 2003
    Publication date: January 8, 2004
    Applicant: Medical Research Council
    Inventors: Phillipp Holliger, Farid Ghadessy, Jennifer Lee Ong